This Cooperative Agreement award of $4,500,000.00 from the Centers for Disease Control and Prevention (CDC) under the CFDA 93.283 "Centers for Disease Control and Prevention Investigations and Technical Assistance" program will support the "NIGERIA: PARTNERSHIP FOR ORGANIZED IMMUNIZATION AND SURVEILLANCE SERVICES FOR EVERY CHILD'S HEALTH ACTIVITY" over a 5-year period from September 30, 2024 to September 29, 2029. The prime awardee, Catholic Relief Services - United States...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $6,749,031 cooperative agreement titled "The USHINDI Project" under the Global AIDS program (CFDA 93.067) to the Association De Sante Familiale (ASF), a local non-profit in the Democratic Republic of the Congo (DRC), with support from PATH, a U.S.-based international NGO. The project aims to enhance access to comprehensive HIV/AIDS services and achieve epidemic control in seven health zones in Haut-Katanga province...
The Centers for Disease Control and Prevention (CDC) awarded a $3,710,204 cooperative agreement under the Global AIDS program (CFDA 93.067) to Humana People To People Congo (Hpp-Congo), a non-profit organization operating in the Democratic Republic of the Congo. The funding supports the "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA" project, which aims to address HIV/AIDS prevention, testing, treatment, and care in Kinshasa. The 5-year cooperative agreement, awarded on September 30,...
This $20,084,340 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the CFDA 93.283 "Centers for Disease Control and Prevention Investigations and Technical Assistance" program will provide technical and science support services to implement the President's Emergency Plan for AIDS Relief (PEPFAR) in the Republic of Rwanda. The 5-year award, effective from Sep 30, 2024 to Sep 29, 2029, will be managed by the Rwanda Biomedical Center, a non-profit...
This $820,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) is intended to strengthen routine immunization and vaccine equity in the Democratic Republic of the Congo and Brazil. The prime awardee, World Vision Inc., is a global non-profit organization that specializes in delivering humanitarian aid, emergency relief, and development services worldwide. Through this 5-year award, which runs...
This $4,050,000 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) will support Save The Children Federation, Inc. in strengthening immunization program implementation in sub-national geographies in Ethiopia. The 5-year award, beginning on September 30, 2024, will focus on enhancing disease surveillance, epidemiological investigations, and technical capacity building to improve...
This $6,000,000 Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security program (CFDA 93.318), supports comprehensive global health security and capacity building initiatives by the National Health Laboratory Service (NHLS) in South Africa. Key activities funded under this 5-year award include: strengthening infectious disease...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) provides $5,600,000.00 to Interchurch Medical Assistance, Inc. over the period of Sep 30, 2024 to Sep 29, 2029. The award is intended to strengthen immunization program implementation in sub-national consequential geographies. As the prime grantee, Interchurch Medical Assistance will leverage its expertise in global health, health systems...
This federal Cooperative Agreement award in the amount of $1,770,000.00 was issued by the U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award, with a period of performance from September 30, 2024 to September 29, 2029, is intended to support advancing diagnostic network optimization, stepwise laboratory accreditation, and integrated one health specimen transport in...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $11,097,080 to Global Health Systems Solutions (GHSS) to build laboratory capacity and improve the quality of HIV testing services in the Democratic Republic of the Congo (DRC). The key objectives include scaling up quality assurance and improvement for HIV rapid testing and other diagnostic services, implementing quality management systems in diagnostic...